Skip to main content

. 1968 Dec;53(6):883–901.

Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration).

S Goldfischer, I Sternlieb

PMCID: PMC2013542 PMID: 4177374

885

Images in this article

Fig. 13 and 14
on p.901

Fig. 15
on p.901

Fig. 1
on p.895

Fig. 2
on p.895

Fig. 3
on p.897

Fig. 4
on p.897

Fig. 5
on p.897

Fig. 6
on p.897

Fig. 7
on p.899

Fig. 8
on p.899

Fig. 9
on p.899

Fig. 10
on p.899

Fig. 11
on p.899

Fig. 12
on p.900

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ANDERSON P. J., POPPER H. Changes in hepatic structure in Wilson's disease. Am J Pathol. 1960 May;36:483–497. [PMC free article] [PubMed] [Google Scholar]
BARKA T., SCHEUER P. J., SCHAFFNER F., POPPER H. STRUCTURAL CHANGES OF LIVER CELLS IN COPPER INTOXICATION. Arch Pathol. 1964 Oct;78:331–349. [PubMed] [Google Scholar]
Brückmann G., Zondek S. G. Iron, copper and manganese in human organs at various ages. Biochem J. 1939 Nov;33(11):1845–1857. doi: 10.1042/bj0331845. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dastur D. K., Manghani D. K. The liver in Wilson's disease. Some histochemical and histological aspects. Indian J Pathol Bacteriol. 1967 Apr;10(2):177–183. [PubMed] [Google Scholar]
GOLDFISCHER S. THE LOCALIZATION OF COPPER IN THE PERICANALICULAR GRANULES (LYSOSOMES) OF LIVER IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION) . Am J Pathol. 1965 Jun;46:977–983. [PMC free article] [PubMed] [Google Scholar]
Goldfischer S. Demonstration of copper and acid phosphatase activity in hepatocyte lysosomes in experimental copper toxicity. Nature. 1967 Jul 1;215(5096):74–75. doi: 10.1038/215074a0. [DOI] [PubMed] [Google Scholar]
Goldfischer S., Moskal J. Electron probe microanalysis of liver in Wilson's disease. Simultaneous assay for copper and for lead deposited by acid phosphatase activity in lysosomes. Am J Pathol. 1966 Feb;48(2):305–315. [PMC free article] [PubMed] [Google Scholar]
HAYASHI M. HISTOCHEMICAL DEMONSTRATION OF N-ACETYL-BETA-GLUCOSAMINIDASE EMPLOYING NAPHTHOL AS-BI N-ACETYL-BETA -GLUCOSAMINIDE AS SUBSTRATE. J Histochem Cytochem. 1965 May-Jun;13:355–360. doi: 10.1177/13.5.355. [DOI] [PubMed] [Google Scholar]
HAYASHI M., NAKAJIMA Y., FISHMAN W. H. THE CYTOLOGIC DEMONSTRATION OF BETA-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT. J Histochem Cytochem. 1964 Apr;12:293–297. doi: 10.1177/12.4.293. [DOI] [PubMed] [Google Scholar]
HOWELL J. S. Histochemical demonstration of copper in copper-fed rats and in hepatolenticular degeneration. J Pathol Bacteriol. 1959 Apr;77(2):473–484. doi: 10.1002/path.1700770218. [DOI] [PubMed] [Google Scholar]
Levi A. J., Sherlock S., Scheuer P. J., Cumings J. N. Presymptomatic Wilson's disease. Lancet. 1967 Sep 16;2(7516):575–579. doi: 10.1016/s0140-6736(67)90735-0. [DOI] [PubMed] [Google Scholar]
Lindquist R. R. Studies on the pathogenesis of hepatolenticular degeneration. I. Acid phosphatase activity in copper-loaded rat livers. Am J Pathol. 1967 Oct;51(4):471–481. [PMC free article] [PubMed] [Google Scholar]
OKINAKA S., YOSHIKAWA M., TOYODA M., MOZAI T., TOYOKURA Y., KAMEYAMA M. Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson's disease. AMA Arch Neurol Psychiatry. 1954 Nov;72(5):573–578. [PubMed] [Google Scholar]
SABATINI D. D., BENSCH K., BARRNETT R. J. Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation. J Cell Biol. 1963 Apr;17:19–58. doi: 10.1083/jcb.17.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
SCHAFFNER F., STERNLIEB I., BARKA T., POPPER H. Hepatocellular changes in Wilson's disease. Histochemical and electron microscopic studies. Am J Pathol. 1962 Sep;41:315–328. [PMC free article] [PubMed] [Google Scholar]
SCHEINBERG I. H., STERNLIEB I. WILSON'S DISEASE. Annu Rev Med. 1965;16:119–134. doi: 10.1146/annurev.me.16.020165.001003. [DOI] [PubMed] [Google Scholar]
STERNLIEB I., SCHEINBERG I. H. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION. JAMA. 1964 Sep 7;189:748–754. doi: 10.1001/jama.1964.03070100042008. [DOI] [PubMed] [Google Scholar]
Sass-Kortsak A. Copper metabolism. Adv Clin Chem. 1965;8:1–67. doi: 10.1016/s0065-2423(08)60412-6. [DOI] [PubMed] [Google Scholar]
Scheuer P. J., Thorpe M. E., Marriott P. A method for the demonstration of copper under the electron microscope. J Histochem Cytochem. 1967 May;15(5):300–301. doi: 10.1177/15.5.300. [DOI] [PubMed] [Google Scholar]
Sternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology. 1968 Sep;55(3):354–367. [PubMed] [Google Scholar]
Sternlieb I., Scheinberg I. H. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med. 1968 Feb 15;278(7):352–359. doi: 10.1056/NEJM196802152780702. [DOI] [PubMed] [Google Scholar]
UZMAN L. L. Histochemical localization of copper with rubeanic acid. Lab Invest. 1956 May-Jun;5(3):299–305. [PubMed] [Google Scholar]
VOGEL F. S., KEMPER L. Biochemical reactions of copper within neural mitochondria, with consideration of the role of the metal in the pathogenesis of Wilson's disease. Lab Invest. 1963 Feb;12:171–179. [PubMed] [Google Scholar]
Verity M. A., Gambell J. K., Reith A. R., Brown W. J. Subcellular distribution and enzyme changes following subacute copper intoxication. Lab Invest. 1967 Apr;16(4):580–590. [PubMed] [Google Scholar]
Yoshikawa M., Mozai T., Hirai S. Clinical and epidemiological studies on hepatocerebral disease in Japan. Prog Brain Res. 1966;21:269–284. doi: 10.1016/s0079-6123(08)64234-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (3.5 MB)

RESOURCES